评估肝转移对患者预后的预测作用：系统评价和荟萃分析。
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis.
机构信息
From the Department of Ophthalmology, University of Michigan, Ann Arbor, MI.
Department of Economics.
出版信息
Cancer J. 2023;29(5):279-284. doi: 10.1097/PPO.0000000000000683.
Abstract
The liver is a common site of metastasis for many primary malignancies, but the quantitative impact on survival is unknown. We performed a systematic review and meta-analysis of 83 studies (604,853 patients) assessing the overall hazard associated with liver metastases by primary tumor type and treatment regimen. The pooled overall survival hazard ratio (HR) for all included studies was 1.77 (95% confidence interval [CI], 1.62-1.93). Patients with breast cancer primaries fared the worst (HR, 2.37; 95% CI, 1.64-3.44), as did patients treated with immunotherapies (HR, 1.86; 95% CI, 1.42-2.42). Liver metastases negatively impact survival, necessitating new approaches to disease management.
摘要
肝脏是许多原发性恶性肿瘤转移的常见部位，但对生存的定量影响尚不清楚。我们对 83 项研究（604853 名患者）进行了系统评价和荟萃分析，评估了按原发性肿瘤类型和治疗方案分类的肝转移的总体风险。所有纳入研究的总体生存风险比（HR）为 1.77（95%置信区间 [CI]，1.62-1.93）。乳腺癌原发患者的预后最差（HR，2.37；95% CI，1.64-3.44），接受免疫治疗的患者也如此（HR，1.86；95% CI，1.42-2.42）。肝转移对生存有负面影响，需要新的疾病管理方法。
相似文献
1
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis.评估肝转移对患者预后的预测作用：系统评价和荟萃分析。
Cancer J. 2023;29(5):279-284. doi: 10.1097/PPO.0000000000000683.
2
The primary tumor location impacts survival outcome of colorectal liver metastases after hepatic resection: A systematic review and meta-analysis.原发肿瘤位置对肝切除术后结直肠肝转移的生存结局有影响：一项系统评价和荟萃分析。
Eur J Surg Oncol. 2019 Aug;45(8):1349-1356. doi: 10.1016/j.ejso.2019.04.017. Epub 2019 Apr 25.
3
Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.新发 IV 期三阴性乳腺癌中特定部位转移和手术的预后价值：基于人群的分析。
Med Sci Monit. 2020 Feb 11;26:e920432. doi: 10.12659/MSM.920432.
4
Risk and prognostic factors of breast cancer with liver metastases.乳腺癌肝转移的风险和预后因素。
BMC Cancer. 2021 Mar 6;21(1):238. doi: 10.1186/s12885-021-07968-5.
5
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.紧密连接蛋白-2是乳腺癌的一个独立负面预后因素，尤其可预测早期肝转移。
Mol Oncol. 2014 Feb;8(1):119-28. doi: 10.1016/j.molonc.2013.10.002. Epub 2013 Oct 14.
6
Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.乳腺癌脑转移患者无脑转移间隔的预后价值。
World Neurosurg. 2019 Aug;128:e157-e164. doi: 10.1016/j.wneu.2019.04.072. Epub 2019 Apr 26.
7
Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis.针对结直肠癌患者肺转移瘤切除术后生存情况的个体数据荟萃分析：肝转移瘤切除史会使预后恶化。
Eur J Surg Oncol. 2018 Jul;44(7):1006-1012. doi: 10.1016/j.ejso.2018.03.011. Epub 2018 Mar 21.
8
Prognostic factors for overall survival after lung metastasectomy in renal cell cancer patients: A systematic review and meta-analysis.肾细胞癌患者肺转移瘤切除术后总生存的预后因素：系统评价和荟萃分析。
Int J Surg. 2017 May;41:70-77. doi: 10.1016/j.ijsu.2017.03.062. Epub 2017 Mar 27.
9
β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases.与雌激素受体状态不同，β-连环蛋白非依赖性WNT信号传导和Ki67在乳腺癌肝转移中具有预后价值且与不良预后相关。
Clin Exp Metastasis. 2016 Apr;33(4):309-23. doi: 10.1007/s10585-016-9780-3. Epub 2016 Feb 9.
10
The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.肿瘤突变负担对乳腺癌生存预后的作用：系统评价和荟萃分析。
BMC Cancer. 2022 Nov 17;22(1):1185. doi: 10.1186/s12885-022-10284-1.
引用本文的文献
1
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer.用于优化转移性去势抵抗性前列腺癌的PSMA靶向放射性配体疗法的生物标志物。
Front Oncol. 2025 Aug 20;15:1583168. doi: 10.3389/fonc.2025.1583168. eCollection 2025.
2
Serum extracellular vesicle microRNAs as potential biomarkers to predict pembrolizumab response and prognosis in metastatic non-small cell lung cancer patients.血清细胞外囊泡微小RNA作为预测转移性非小细胞肺癌患者帕博利珠单抗反应和预后的潜在生物标志物。
Front Immunol. 2025 Jun 4;16:1540906. doi: 10.3389/fimmu.2025.1540906. eCollection 2025.
3
Advances in Vaccine-Based Therapies for Pancreatic Cancer.胰腺癌基于疫苗疗法的进展
J Gastrointest Cancer. 2025 Feb 12;56(1):62. doi: 10.1007/s12029-025-01165-4.
4
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases.福司曲他滨溴丙酰胺（Fostrox）单药治疗肝细胞癌和实体瘤肝转移的1a/1b期研究。
J Hepatocell Carcinoma. 2024 Oct 24;11:2033-2047. doi: 10.2147/JHC.S481410. eCollection 2024.
本文引用的文献
1
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy.错配修复功能健全的结直肠癌肝转移中树突状细胞数量稀少，限制了免疫检查点阻断疗效。
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45). doi: 10.1073/pnas.2105323118.
2
The Liver-Immunity Nexus and Cancer Immunotherapy.肝脏-免疫轴与癌症免疫治疗。
Clin Cancer Res. 2022 Jan 1;28(1):5-12. doi: 10.1158/1078-0432.CCR-21-1193. Epub 2021 Jul 20.
3
Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.按病因和后遗症划分的肝脏相关死亡率变化：根本死因与多种死因。
Popul Health Metr. 2021 Apr 29;19(1):22. doi: 10.1186/s12963-021-00249-0.
4
Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305.艾立布林、Child-Pugh 评分和肝功能检查：来自关键性乳腺癌研究 301 和 305 的经验教训。
Breast Cancer Res. 2021 Mar 18;23(1):33. doi: 10.1186/s13058-021-01407-w.
5
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.肝转移通过巨噬细胞介导的 T 细胞消除来抑制免疫疗法的疗效。
Nat Med. 2021 Jan;27(1):152-164. doi: 10.1038/s41591-020-1131-x. Epub 2021 Jan 4.
6
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis.调节性 T 细胞对肝转移全身免疫和免疫治疗反应的控制。
Sci Immunol. 2020 Oct 2;5(52). doi: 10.1126/sciimmunol.aba0759.
7
The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases.免疫检查点抑制剂在伴肝转移的晚期非小细胞肺癌中的疗效。
J Cancer Res Clin Oncol. 2020 Mar;146(3):777-785. doi: 10.1007/s00432-019-03104-w. Epub 2019 Dec 11.
8
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.晚期癌症患者接受免疫治疗后的转移部位与临床结局的关联。
BMC Cancer. 2019 Aug 29;19(1):857. doi: 10.1186/s12885-019-6073-7.
9
Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.接受纳武单抗治疗的晚期黑色素瘤、肾细胞癌或非小细胞肺癌患者的五年生存率及相关因素
JAMA Oncol. 2019 Oct 1;5(10):1411-1420. doi: 10.1001/jamaoncol.2019.2187.
10
Abnormal Liver Function Induced by Space-Occupying Lesions Is Associated with Unfavorable Oncologic Outcome in Patients with Colorectal Cancer Liver Metastases.占位性病变引起的肝功能异常与结直肠癌肝转移患者的不良肿瘤预后相关。
Biomed Res Int. 2018 May 15;2018:9321270. doi: 10.1155/2018/9321270. eCollection 2018.
Zotero 插件